KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to $8.9 million.

  • Evolent Health's Long-Term Investments fell 4012.73% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year decrease of 4012.73%. This contributed to the annual value of $15.0 million for FY2024, which is 1106.5% down from last year.
  • Evolent Health's Long-Term Investments amounted to $8.9 million in Q3 2025, which was down 4012.73% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Long-Term Investments ranged from a high of $17.6 million in Q2 2023 and a low of $8.9 million during Q3 2025
  • For the 5-year period, Evolent Health's Long-Term Investments averaged around $13.9 million, with its median value being $13.4 million (2021).
  • Data for Evolent Health's Long-Term Investments shows a peak YoY increase of 9502.55% (in 2021) and a maximum YoY decrease of 8663.39% (in 2021) over the last 5 years.
  • Over the past 5 years, Evolent Health's Long-Term Investments (Quarter) stood at $13.0 million in 2021, then fell by 3.94% to $12.5 million in 2022, then skyrocketed by 35.28% to $16.9 million in 2023, then fell by 11.06% to $15.0 million in 2024, then plummeted by 40.42% to $8.9 million in 2025.
  • Its Long-Term Investments stands at $8.9 million for Q3 2025, versus $9.0 million for Q2 2025 and $15.1 million for Q1 2025.